Status:
COMPLETED
Behavioral and Enhanced Perinatal Intervention for Cessation (B-EPIC): Reducing Tobacco Use Among Opioid Addicted Women
Lead Sponsor:
Kristin Ashford
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Cessation
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
This study tests an intervention for tobacco cessation (named B-EPIC) in an established community medication assisted treatment (MAT) clinic for pregnant and postpartum women with opioid dependence. H...
Detailed Description
The study will use a prospective, 2-group, randomized, comparative effectiveness design to determine if the B-EPIC tobacco intervention is superior to tobacco 'treatment as usual (TAU)' for opioid dep...
Eligibility Criteria
Inclusion
- Current diagnosis of opioid dependence with participation in the University of Kentucky Healthcare and Baptist Health Lexington buprenorphine treatment program
- Less than 24 weeks gestation
- Age 18-49 years old
- Diagnosis of current tobacco use disorder
- Read or write in English
Exclusion
- Current prisoner status
- Current severe mental illness (e.g., bipolar disorder with current mania, current suicidal ideation)
- Alcohol or sedative/hypnotic dependence that requires medical intervention
Key Trial Info
Start Date :
December 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 24 2021
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT03796208
Start Date
December 12 2018
End Date
May 24 2021
Last Update
July 15 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Baptist Health Lexington
Lexington, Kentucky, United States, 40503
2
University of Kentucky Polk Dalton Clinic
Lexington, Kentucky, United States, 40536